Resources on Monoclonal Antibody Treatment for COVID-19 

Situation Report | August 30, 2021    

The New York City Department of Health and Mental Hygiene posted updated information on monoclonal antibody (mAb) treatment for COVID-19. 

The materials are available here and here.

Monoclonal antibody is the only authorized treatment option for patients with mild to moderate COVID-19 who are at high risk of developing severe illness. 

Treatment is authorized for people who meet all of the following criteria:  

  • Tested positive for COVID-19.
  • Have had mild to moderate COVID-19 symptoms for 10 days or less.
  • Are age 12 or older and weigh at least 88 pounds.
  • Are at a high risk for severe COVID-19 illness, including older adults, people who are pregnant and people with certain underlying health conditions, such as obesity, diabetes, chronic kidney disease or a weakened immune system.

A list of treatment sites in the Downstate New York region and information on how to refer patients can be found on the Health Information Tool for Empowerment (HITE) site. Additional treatment sites may be found on the Department of Health and Human Services’ treatment locator.  

NYC Health + Hospitals offers mAb treatment throughout NYC and accepts patient referrals regardless of immigration status or ability to pay. Patients or providers can contact Health + Hospitals by visiting this website or calling 212-COVID19 (212-268-4319) to talk to a provider who can determine eligibility and schedule treatment.